Chi-Cheng Huang1, Jung-Cheng Hsu1, Yen-Wen Wu2, Shin-Rong Ke1, Jih-Hsin Huang3, Kuan-Ming Chiu3, Pen-Chih Liao4. 1. Division of Cardiology, Cardiovascular Medical Center, Far-Eastern Memorial Hospital, New Taipei City, Taiwan. 2. Division of Cardiology, Cardiovascular Medical Center, Far-Eastern Memorial Hospital, New Taipei City, Taiwan; National Yang-Ming University School of Medicine, Taipei, Taiwan. 3. Division of Cardiovascular Surgery, Cardiovascular Medical Center, Far-Eastern Memorial Hospital, New Taipei City, Taiwan. 4. Division of Cardiology, Cardiovascular Medical Center, Far-Eastern Memorial Hospital, New Taipei City, Taiwan. Electronic address: dr.liaopc@msa.hinet.net.
Abstract
BACKGROUND: The mortality of patients with ST-segment elevation myocardial infarction (STEMI) and refractory cardiogenic shock (RCS) is high. Extracorporeal membrane oxygenation (ECMO) before percutaneous coronary intervention (PCI) has shown some favorable results, but this may delay door-to-balloon (D2B) time. Whether the benefit surpasses the risk of longer D2B time remains controversial. METHODS: From January 2005 to December 2014, there were 46 patients with STEMI RCS who received ECMO and PCI. Comparison was made between patients whose ECMO were setup before (n = 12) and after (n = 34) the coronary angiography. RESULTS: There were no significant differences on the baseline characteristics. The ECMO before PCI group had significantly better six-month survival (58.3% vs. 14.7%, p = 0.006), and the benefit persisted to the end of two-year follow-up (41.7% vs. 11.8%, p = 0.045). The rates of neurological, vascular, or bleeding complications were not different between the groups. ECMO before PCI was associated with a nonsignificant increase of median D2B time (30 min) and decrease of patients achieving D2B time < 90 min (9.1% vs. 32.0%). After adjusting for GRACE score, gender, D2B time, complete revascularization, ECMO before PCI and shock index < 0.8 before PCI were significantly associated with six-month survival. CONCLUSIONS: In STEMI RCS patients, ECMO before PCI improves both short- and long-term outcomes, even if it nonsignificantly increases the D2B time. Our data suggests that ECMO before PCI is a reasonable and safe strategy in this particularly-ill population.
BACKGROUND: The mortality of patients with ST-segment elevation myocardial infarction (STEMI) and refractory cardiogenic shock (RCS) is high. Extracorporeal membrane oxygenation (ECMO) before percutaneous coronary intervention (PCI) has shown some favorable results, but this may delay door-to-balloon (D2B) time. Whether the benefit surpasses the risk of longer D2B time remains controversial. METHODS: From January 2005 to December 2014, there were 46 patients with STEMI RCS who received ECMO and PCI. Comparison was made between patients whose ECMO were setup before (n = 12) and after (n = 34) the coronary angiography. RESULTS: There were no significant differences on the baseline characteristics. The ECMO before PCI group had significantly better six-month survival (58.3% vs. 14.7%, p = 0.006), and the benefit persisted to the end of two-year follow-up (41.7% vs. 11.8%, p = 0.045). The rates of neurological, vascular, or bleeding complications were not different between the groups. ECMO before PCI was associated with a nonsignificant increase of median D2B time (30 min) and decrease of patients achieving D2B time < 90 min (9.1% vs. 32.0%). After adjusting for GRACE score, gender, D2B time, complete revascularization, ECMO before PCI and shock index < 0.8 before PCI were significantly associated with six-month survival. CONCLUSIONS: In STEMI RCS patients, ECMO before PCI improves both short- and long-term outcomes, even if it nonsignificantly increases the D2B time. Our data suggests that ECMO before PCI is a reasonable and safe strategy in this particularly-ill population.
Authors: Shreyas Venkataraman; Abhishek Bhardwaj; Peter Matthew Belford; Benjamin N Morris; David X Zhao; Saraschandra Vallabhajosyula Journal: Medicina (Kaunas) Date: 2022-02-01 Impact factor: 2.430
Authors: Silver Heinsar; Sacha Rozencwajg; Jacky Suen; Gianluigi Li Bassi; Maximilian Malfertheiner; Leen Vercaemst; Lars Mikael Broman; Matthieu Schmidt; Alain Combes; Indrek Rätsep; John F Fraser; Jonathan E Millar Journal: Intensive Care Med Exp Date: 2020-05-25
Authors: Ole Kristian Lerche Helgestad; Jakob Josiassen; Christian Hassager; Lisette Okkels Jensen; Lene Holmvang; Nanna Louise Junker Udesen; Henrik Schmidt; Hanne Berg Ravn; Jacob Eifer Moller Journal: Open Heart Date: 2020-03-04